BOOST Pharma was founded based on research from Karolinska Institutet, focusing on novel cell therapy treatments for osteogenesis imperfecta, OI. The company’s treatment has a unique position on the market, since it targets the underlying condition causing fractures and bone deformities, unlike any other product under development.